In the search for effective COVID-19 treatments, many drugs failed to live up to their early promise. The antiviral molnupiravir performed well in trials, reducing hospitalizations and deaths among ...

Merck, one of America’s largest pharmaceutical companies, put in an emergency use authorization request for a pill that may be the first to treat COVID-19. Pakistani who wounded ex-Prime Minister Khan ...

A new study suggests that the antiviral Molnupiravir may “paradoxically” be driving COVID-19 mutations, creating variants of concern. What is going on? It is all about molnupiravir’s mode of action ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The US Food and Drug Administration (FDA) granted emergency use authorization to Merck's antiviral ...

A handout photo of an experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP SEOUL (Reuters) - South Korea's drug safety ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The investigational oral antiviral molnupiravir ...

Efforts to find an easy, early COVID-19 treatment may have finally panned out An at-home pill against coronavirus halves the chance that people newly diagnosed with COVID-19 will land in the hospital ...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Photo by Martin Sanchez on Unsplash Merck ...